AAAAAA
Results:
1-7
|
Results: 7
Authors:
Zhou, HM
Bolon, I
Nichols, A
Wohlwend, A
Vassalli, JD
Citation: Hm. Zhou et al., Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice, CANCER RES, 61(3), 2001, pp. 970-976
Authors:
Conne, B
Stutz, A
Vassalli, JD
Citation: B. Conne et al., The 3 ' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?, NAT MED, 6(6), 2000, pp. 637-641
Authors:
Zhou, HM
Nichols, A
Meda, P
Vassalli, JD
Citation: Hm. Zhou et al., Urokinase-type plasminogen activator and its receptor synergize to promotepathogenic proteolysis, EMBO J, 19(17), 2000, pp. 4817-4826
Authors:
Zhou, HM
Nichols, A
Wohlwend, A
Bolon, I
Vassalli, JD
Citation: Hm. Zhou et al., Extracellular proteolysis alters tooth development in transgenic mice expressing urokinase-type plasminogen activator in the enamel organ, DEVELOPMENT, 126(5), 1999, pp. 903-912
Authors:
Madani, R
Hulo, S
Toni, N
Madani, H
Steimer, T
Muller, D
Vassalli, JD
Citation: R. Madani et al., Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice, EMBO J, 18(11), 1999, pp. 3007-3012
Authors:
Scherrer, A
Wohlwend, A
Kruithof, EKO
Vassalli, JD
Sappino, AP
Citation: A. Scherrer et al., Plasminogen activation in human acute leukaemias, BR J HAEM, 105(4), 1999, pp. 920-927
Authors:
Stutz, A
Huarte, J
Conne, B
Vassalli, JD
Citation: A. Stutz et al., Approaches to study translational control in mouse oocytes, ADV MOL BIO, 1999, pp. 83-100
Risultati:
1-7
|